Key facts
- This page summarizes Matthew Gline's Form 4 filing for Roivant Sciences Ltd. (ROIV).
- 7 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 12 Nov 2026, 21:01.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Other
Other
Other
Other
Other
Other
Tax liability
Additional SEC filing notes
Footnote F1
Represents the sale of Common Shares pursuant to the Issuer's nondiscretionary "sell-to-cover" policy in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of a portion of the performance restricted stock units ("PSUs") granted to the reporting person on July 26, 2024 following the achievement of both the performance-based vesting conditions (the "Performance Condition") and service-based vesting conditions (the "Service Condition") applicable to such PSUs. Additional PSUs that have satisfied both the Performance Condition and the Service Condition will be settled in one or more future instalments in accordance with their terms.
Footnote F2
Except as noted below, the remaining Common Shares issued on settlement of such PSUs (after satisfaction of tax withholding obligations) are subject to a two-year post-vesting holding period before such Common Shares may be sold, measured from the date the Service Condition of the PSUs is satisfied. As previously reported, the Issuer and the reporting person entered into a letter agreement (the "Gline Letter Agreement") waiving the two-year holding period referenced in the preceding sentence solely in connection with and concurrent with the reporting person donating such Common Shares to a donor-advised fund on or before December 31, 2026. The reporting person has agreed that, upon any such donation, an equivalent two-year holding period will apply to a number of Common Shares underlying the award of stock options granted to the reporting person on April 20, 2022.
Footnote F3
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.88 to $40.88, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.
Footnote F4
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.89 to $41.35, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.
Footnote F5
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.87 to $41.86, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.
Footnote F6
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.87 to $42.22, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.
Footnote F7
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.96 to $40.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.
Footnote F8
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.96 to $41.50, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.
Footnote F9
Represents the "net settlement" by the Issuer of PSUs pursuant to the Issuer's nondiscretionary policy in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of a portion of such PSUs following the achievement of both the Performance Condition and the Service Condition applicable to such PSUs.